Strados Labs

11/12/2025

Tomorrow we are excited to join clinicians, researchers, and patient advocates in Chicago for Pulmonary Fibrosis Foundation's , the leading event advancing pulmonary fibrosis (PF) and interstitial lung disease (ILD) science and awareness.

We’re honored to contribute to this collaborative effort to expand education, improve treatment understanding, and accelerate progress toward better outcomes for people living with these conditions.

Our team will share data on cough sound intensity measured with the RESP® Biosensor, exploring its potential as a new objective cough measure in respiratory research.

We hope to see you there!

11/05/2025

A cough that won’t go away is often dismissed, but for some, it’s the first sign of a serious lung condition.

A recent Pulmonary Fibrosis News article shares how idiopathic pulmonary fibrosis (IPF) can take months, or even years, to diagnose. Because symptoms like cough and shortness of breath are common and nonspecific, patients often face misdiagnoses and delays that can impact treatment options and outcomes.

At Strados Labs, we’re helping clinicians identify and track lung disease earlier through objective, continuous respiratory sound data. By making changes in lung health easier to detect, we aim to support faster diagnosis and more informed care for patients with conditions like IPF.

Read the full article here: https://bit.ly/4o4uIqc

Columnist Sam Kirton's diagnostic journey was relatively short compared with that of other idiopathic pulmonary fibrosis (IPF) patients.

11/04/2025

In less than two weeks, our team is gearing up for the Pulmonary Fibrosis Foundation's (Nov 13–15), a global gathering focused on advancing research, education, and care for patients with pulmonary fibrosis (PF) and interstitial lung disease (ILD).

Global Director Shane Krauss and Director of Data Science Tom deLaubenfels will share our latest research on cough sound amplitude as an emerging objective measure, highlighting the potential of the RESP® Biosensor to offer new insights into cough burden in patients with PF and ILD.

If you’ll be at the Summit, message us to connect or learn more about the event: https://bit.ly/48e5n8A

10/28/2025

We’re proud to share our second poster presentation from the European Respiratory Society (ERS) Congress 2025:

“Automated Cough Identification in Chronic Cough from Real-World Recordings by the CoughCheck™ Algorithm.”

This work builds on the CoughCheck™ performance results we presented earlier this year at ATS 2025.

Objective cough frequency continues to be a key measure in cough research. Automated cough detection through a validated algorithm offers a practical approach for use cases where the FDA gold standard, manual cough counting, may not be required such as subject screening.

Our latest findings demonstrate strong recall and precision performance of our CoughCheck™ algorithm in real-world settings.

📑 View the digital poster: https://lnkd.in/eMZ-BjEz

10/24/2025

October is National Healthy Lung Month: a time to raise awareness of how daily choices, environmental factors, and preventive care impact long-term respiratory health.

Conditions like , , , and affect millions worldwide, highlighting the importance of early detection and proactive care. Simple steps like improving indoor air quality, staying active, and keeping up with vaccinations and screenings can make a lasting difference in how we breathe and live.

Learn more about ways to protect your lungs and support healthier breathing year-round: https://bit.ly/3WpBLOh

Every day, your lungs work around the clock, taking in oxygen and releasing carbon dioxide. On average, a person breathes about 22,000 times a day. Yet most people rarely think about lung health until breathing becomes difficult. Conditions like asthma, chronic obstructive pulmonary disease (COPD),....

10/23/2025

In less than two weeks, leaders from , , , and will gather in Boston for the Collaborating for Novel Solutions Summit (CNS Summit), a conference that unites innovators to exchange ideas and shape the future of life sciences.

Our Global Director, Shane Krauss, will connect with R&D and clinical leaders to discuss how AI, digital biomarkers, decentralized trials, and other emerging technologies are transforming research design and delivery.

Join us at our poster from 5-7pm on Monday and Tuesday to learn how pharmaceutical sponsors are including cough and lung acoustic measures in their clinical trials to elevate understanding of treatment response.

See you in Boston!

10/13/2025

We are excited to be attending and sponsoring HLTH USA next week from October 19-22 in Las Vegas!

Come visit Strados Labs in the Science Center Pavilion (2562, Level 2 of the Exhibit Hall) to learn how we’re transforming respiratory surveillance and care from hospital to home.

Our CEO & Founder, Nick Delmonico and Marketing Manager, Gabe Steerman, will be onsite throughout the event.

Please message Nick to schedule a meeting, or stop by our kiosk to connect in person!

10/09/2025

We were thrilled to present two abstracts at ERS Congress last week, where our Director of Data Science, Tom deLaubenfels, PhD, shared new research on objectively quantifying the burden of cough bouts using the RESP® Biosensor.

In this presentation, Dr. deLaubenfels shares how cough intensity, captured continuously during real-world recordings, may provide deeper insight into cough severity and disease impact across subacute and chronic cough populations.

This work was part of two new posters presented at ERS 2025:

- Objectively Quantifying the Burden of Cough Bouts in Chronic and Subacute Cough
- Automated Cough Identification in Chronic Cough from Real-World Recordings by a Custom Machine Learning Algorithm

🔗 Digital versions of both posters are now available: view them here!
https://bit.ly/3KF8PPP
https://bit.ly/4ogzjpw

10/03/2025

Decentralized Clinical Trials (DCTs) are transforming data collection, expanding access, increasing data frequency, and reducing patient burden. But they bring challenges: multiple data sources, device variability, integration complexity, and strict privacy rules.

A recent Fierce Biotech article outlines key strategies: pre-trial tool validation, real-time monitoring, standardized collection, and strong data management. Success in DCTs demands more than tech. It requires solid infrastructure, regulatory alignment, and expert partners: https://bit.ly/3Jerzoz

At Strados Labs, our RESP® Biosensor and cloud platform are built for decentralized and hybrid trials, securely capturing continuous, high-fidelity lung sound recordings in real-world settings. We help sponsors improve data quality, minimize gaps, detect changes earlier, and meet global privacy standards.

As DCTs become the norm, respiratory endpoints deserve the same rigor as any other measure. We make sure they get it.

1. Introduction | Decentralized Clinical Trials (DCTs) are transforming how we collect clinical data, but this evolution brings unprecedented challenges in data quality, complexity, and integration.

09/25/2025

Today on World Lung Day, we’re reminded that healthy lungs are essential for healthy lives.

Respiratory diseases like asthma, COPD, pulmonary fibrosis, and bronchiectasis affect millions worldwide. Lung sounds such as cough, wheeze, and crackles are more than symptoms: they’re signals clinicians use to understand disease burden and patient health.

Across healthcare and research, new innovations are helping us continuously measure and monitor these signals, allowing for earlier interventions and better outcomes. At Strados Labs, we’re proud to be part of this movement to advance respiratory health.

On World Lung Day, we stand with patients, caregivers, and researchers working to protect and improve lung health everywhere.

09/24/2025

🫁 ERS is almost here!

In just a few days, thousands of respiratory professionals will gather in Amsterdam and online to share new science, exchange ideas, and shape the future of care.

Here’s where to find Strados Labs during the Congress:

• Exhibit Hall: Hall A, Booth 11: Open Sun, Sept 28 - Tues, Sept 30. Stop by to hear our latest updates and learn how the RESP Biosensor can enable novels insights into your patients' respiratory status
• Poster Presentations: Two posters in the Chronic Cough Poster Session (Session 46, PS-17) on Sunday, Sept 28, 8:00–9:30 a.m., exploring innovative ways to measure cough burden and apply machine learning.
• Award Sponsorship: On Tuesday, Sept 30, we’re honored to sponsor the ERS Grant for Best Abstract in Symptoms and Quality of Life in ILD (5:15–6:35 p.m., Room Elicium 2).

We look forward to connecting with clinicians, researchers, and partners working to advance respiratory health.

See you in Amsterdam!

09/18/2025

We are proud to support research on Interstitial Lung Disease (ILD) at .

This year, Strados Labs is sponsoring the ERS Grant for Best Abstract in Symptoms and Quality of Life in ILD, which will be awarded on Tuesday, Sept 30, 5:15–6:35 p.m. in Room Elicium 2. The grant recognizes research that expands our understanding of ILD, particularly how symptoms are experienced by patients and how innovations in care can improve quality of life.

Supporting this grant reflects our mission at Strados Labs: advancing patient-centered research and empowering clinicians with real-world respiratory data to improve outcomes. We look forward to celebrating the researchers driving progress for people living with ILD.